RDHL Stock — Price, Charts & Analysis

Redhill Biopharma Ltd. American Depositary Shares (RDHL) has no trailing P/E shown and a forward P/E of 20.83x. This places RDHL in a moderate earnings multiple territory based on the valuation data currently available on Worldtickers.

RDHL trades with 20.83x earnings on Worldtickers. Use valuation together with growth, balance sheet strength, and risk before deciding whether RDHL looks overvalued or undervalued.

RDHL's P/E of 20.83x should be judged against Healthcare peers, growth rate, margins, and balance sheet quality. A lower P/E may indicate value, while a higher P/E often means investors expect stronger future growth.

RDHL's trailing EPS is $0.00 and forward EPS is $0.03.

EPS, or earnings per share, shows how much profit Redhill Biopharma Ltd. American Depositary Shares generated for each share. RDHL's trailing EPS is $0.00, and investors usually prefer EPS that is positive and growing over time.

Redhill Biopharma Ltd. American Depositary Shares has a market cap of $3.80M, making RDHL a small-cap stock based on the current market value shown on Worldtickers.

RDHL's latest stock price on Worldtickers is $0.63. The latest move is -$0.00 or -0.48%. Use the live quote, chart, volume, and 52-week range to judge the current trading context.

RDHL's quote includes a latest price of $0.63. The market open is $0.62. Previous close is $0.63. The intraday range is $0.62 to $0.65.

RDHL is down in the latest quote, with a move of -$0.00 or -0.48%. To understand the reason, compare this move with news, earnings updates, analyst changes, sector performance, and market-wide direction.

RDHL generated $286.00K in trailing revenue.

No, RDHL does not show positive profitability metrics in the latest data available on Worldtickers. Net income to common shareholders is -$8.08M.

Gross margin is 100.00%. Margins show how efficiently Redhill Biopharma Ltd. American Depositary Shares turns revenue into profit.

Redhill Biopharma Ltd. American Depositary Shares carries $1.07M and holds $3.97M in cash.

RDHL holds $3.97M on its balance sheet.

RDHL's book value per share is $0.84.

Institutions hold 5.19% of RDHL shares. Insiders hold 0.00% of shares. Ownership mix helps investors understand how much of Redhill Biopharma Ltd. American Depositary Shares is held by professional investors and company insiders.

RDHL has 6.08M shares outstanding. Float shares are 4.2M. Share count affects market cap, EPS, ownership percentages, and the impact of buybacks or dilution.

Insider activity can be useful context for RDHL, especially when multiple executives buy shares with their own money. Insider selling is harder to interpret because executives may sell for taxes, diversification, or planned compensation reasons.

Forward EPS for RDHL is $0.03. For earnings, investors usually watch EPS, revenue, margins, guidance, and management commentary.

RDHL's trailing EPS is $0.00. Forward EPS is $0.03. Use the earnings section on the page to compare reported results, estimates, and trend changes when those datasets are available.

RDHL is in the Healthcare sector. Its earnings multiple is 20.83x. Compare these figures with sector peers before deciding whether Redhill Biopharma Ltd. American Depositary Shares is stronger or weaker than average.

RDHL trades at $0.63. The stock trades at 20.83x earnings. Whether to invest depends on your risk tolerance, time horizon, diversification, and view of Redhill Biopharma Ltd. American Depositary Shares's fundamentals.

RDHL risks include company execution, valuation, competition in Healthcare, interest rates, and broad market volatility. Beta is 4.90, which helps estimate market sensitivity. No single stock should be evaluated without portfolio context.

RDHL should be compared with companies in Drug Manufacturers - Specialty & Generic. Its earnings multiple is 20.83x. Useful comparison points include revenue growth, margins, debt, cash flow, valuation, analyst targets, and price momentum.

Redhill Biopharma Ltd. American Depositary Shares (RDHL) operates in Healthcare, specifically Drug Manufacturers - Specialty & Generic. RedHill Biopharma Ltd., a specialty biopharmaceutical company, primarily focuses on gastrointestinal and infectious diseases. The company develops and commercializes Talicia for the treatment of H. pylori infection in adults; and Aemcolo for the treatment of travelers' diarrhea in adults. Its pipeline consists of five therapeutic candidates, which are in clinical development include opaganib for treating patients hospitalized with SARS-CoV-2 severe COVID-19 pneumonia, prostate cancer, nuclear radiation protection;

RDHL trades on NasdaqCM. Exchange context matters because trading hours, liquidity, currency, and settlement rules can differ across markets.

RDHL stock is priced in USD on Worldtickers. Currency matters for international investors because exchange-rate moves can affect local-currency returns.

Redhill Biopharma Ltd. American Depositary Shares's official website listed on Worldtickers is www.redhillbio.com. Investor relations pages are useful for earnings releases, annual reports, filings, and shareholder presentations.

Redhill Biopharma Ltd. American Depositary Shares employs about 13 people based on the latest company profile data available on Worldtickers. Workforce size helps investors understand company scale and operating complexity.

Redhill Biopharma Ltd. American Depositary Shares is headquartered in Tel Aviv-Yafo, Israel. Headquarters location can matter for currency, regulation, tax, labor market, and regional economic exposure.

RDHL is in the Healthcare sector and the Drug Manufacturers - Specialty & Generic industry. Sector context helps investors compare valuation, growth, margins, and risk against similar companies.

RDHL has traded between $0.57 and $2.79 over the past 52 weeks. At $0.63, it is 77.60% below the high and 9.65% above the low. The 52-week range helps gauge long-term price momentum.

RDHL is below both its 50-day and 200-day moving averages, which is a common downtrend signal. Its 50-day moving average is $0.73 and its 200-day moving average is $0.96.

RDHL's RSI is 44.30. Readings below 30 are commonly viewed as oversold, above 70 as overbought, and the current reading suggests a neutral momentum setup.

RDHL's latest RSI reading is 44.30, which points to neutral momentum today. Traders usually confirm RSI with volume, trend, and nearby support or resistance.

Key support for RDHL is near $0.57. Key resistance is near $0.73. Breaks above resistance or below support can change the short-term technical setup.

RDHL's nearest reported support level is $0.57. A clean break below support can weaken the short-term setup, while repeated bounces can show demand.

RDHL's nearest reported resistance level is $0.73. A breakout above resistance can improve momentum, especially when volume confirms the move.

RDHL trades about 196.3K shares daily on average. The latest displayed volume is 15.38K shares. Volume helps show liquidity and whether trading interest is unusually high or low.

RDHL's MACD is 0.01, which is a positive momentum reading. MACD should be reviewed with price trend, moving averages, RSI, volume, and support or resistance levels.

RDHL is below both its 50-day and 200-day moving averages, which is a common downtrend signal. RSI is 44.30 (neutral). MACD is bullish. Nearest support is around $0.57. Resistance is around $0.73. A buy decision should also consider valuation, earnings quality, risk tolerance, and position sizing.

MA20 is $0.63 (-1.15% from price). MA50 is $0.73 (-14.05% from price). MA200 is $0.96 (-35.17% from price). The moving-average stack helps separate short-term momentum from long-term trend risk.

The server report currently confirms daily moving-average levels rather than a separate EMA-only value. RDHL's MA20 is $0.63. MA50 is $0.73. For EMA-specific overlays, use the live chart indicators and compare EMA direction with RSI, MACD, volume, support, and resistance.

RDHL's pivot is near $0.61. Support is near $0.57. Resistance is near $0.73. Price holding above pivot can support a constructive setup, while rejection near resistance can cap momentum.

The next upper resistance zone is near $0.70. These levels help define risk and possible follow-through zones after a breakout or breakdown.

RDHL's Bollinger range is roughly $0.55 to $0.72. Band width is near 26.22%. Price near the upper band can show stretched upside momentum, while price near the lower band can show downside pressure or a possible mean-reversion zone.

RDHL's ATR-based typical daily range is about 8.55%. ATR helps size risk because wider ranges usually require wider stops or smaller position sizes.

Latest volume is 15.38K shares. Average volume is about 196.3K shares. Breakouts with rising relative volume are usually more reliable than moves on light participation.

RDHL's all-time high shown on Worldtickers is $22,220.00. Its all-time low is $0.57. All-time levels provide long-range context, but recent fundamentals and market conditions matter more for current decisions.

RDHL has a beta of 4.90, meaning it has historically been more volatile than the broad market. Beta is useful for judging how much a stock may move during broad market swings.